| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activity | 1.04e-04 | 654 | 58 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | nerve growth factor binding | 2.30e-04 | 8 | 58 | 2 | GO:0048406 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 3.90e-04 | 49 | 58 | 3 | GO:0004180 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 5.37e-04 | 12 | 58 | 2 | GO:0043121 | |
| GeneOntologyMolecularFunction | histone chaperone activity | 8.50e-04 | 15 | 58 | 2 | GO:0140713 | |
| MousePheno | parietal capsular epithelium metaplasia | 2.90e-05 | 3 | 44 | 2 | MP:0011502 | |
| Domain | Propept_inh | 1.87e-05 | 17 | 58 | 3 | IPR009020 | |
| Domain | - | 2.62e-04 | 8 | 58 | 2 | 3.30.70.340 | |
| Domain | Propep_M14 | 2.62e-04 | 8 | 58 | 2 | PF02244 | |
| Domain | M14A_act_pep | 2.62e-04 | 8 | 58 | 2 | IPR003146 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 7.23e-04 | 13 | 58 | 2 | IPR003112 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | SM00284 | |
| Domain | OLF | 7.23e-04 | 13 | 58 | 2 | PF02191 | |
| Domain | MAM_1 | 1.11e-03 | 16 | 58 | 2 | PS00740 | |
| Domain | MAM | 1.25e-03 | 17 | 58 | 2 | SM00137 | |
| Domain | MAM | 1.40e-03 | 18 | 58 | 2 | PF00629 | |
| Domain | Zn_pept | 1.40e-03 | 18 | 58 | 2 | SM00631 | |
| Domain | MAM_dom | 1.40e-03 | 18 | 58 | 2 | IPR000998 | |
| Domain | MAM_2 | 1.40e-03 | 18 | 58 | 2 | PS50060 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.57e-03 | 19 | 58 | 2 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 1.74e-03 | 20 | 58 | 2 | PS00132 | |
| Domain | Peptidase_M14 | 2.30e-03 | 23 | 58 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 2.30e-03 | 23 | 58 | 2 | IPR000834 | |
| Domain | - | 3.90e-03 | 207 | 58 | 4 | 1.25.40.10 | |
| Domain | ConA-like_dom | 4.76e-03 | 219 | 58 | 4 | IPR013320 | |
| Domain | TPR-like_helical_dom | 5.91e-03 | 233 | 58 | 4 | IPR011990 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A1 OLFML2A FKBP10 ABCB7 ATR PTPRK MPZL1 SEL1L3 RNF213 SMARCE1 FUT8 CTSA | 5.59e-07 | 1201 | 58 | 12 | 35696571 |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22215678 | ||
| Pubmed | 4.18e-06 | 19 | 58 | 3 | 20504901 | ||
| Pubmed | In vivo regulation of plasminogen function by plasma carboxypeptidase B. | 8.19e-06 | 3 | 58 | 2 | 12417566 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17988229 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8662763 | ||
| Pubmed | The human plasma proteome: a nonredundant list developed by combination of four separate sources. | 8.46e-06 | 165 | 58 | 5 | 14718574 | |
| Pubmed | A genome-wide association study for age-related hearing impairment in the Saami. | 1.64e-05 | 4 | 58 | 2 | 20068591 | |
| Pubmed | Early embryonic expression of murine coagulation system components. | 2.54e-05 | 34 | 58 | 3 | 11154109 | |
| Pubmed | Prickle1 is necessary for the caudal migration of murine facial branchiomotor neurons. | 2.72e-05 | 5 | 58 | 2 | 24927917 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 20651253 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 17118963 | ||
| Pubmed | ATRX PTPRK RSPH1 PCSK6 NASP N4BP2L2 SMARCE1 USP9Y FUT8 INTS8 | 4.75e-05 | 1285 | 58 | 10 | 35914814 | |
| Pubmed | ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. | 7.60e-05 | 8 | 58 | 2 | 20381197 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 22164283 | ||
| Pubmed | 9.67e-05 | 645 | 58 | 7 | 25281560 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 26611327 | ||
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 19064565 | ||
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 16103213 | ||
| Pubmed | 2.60e-04 | 533 | 58 | 6 | 25544563 | ||
| Pubmed | Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply. | 2.83e-04 | 15 | 58 | 2 | 22407294 | |
| Pubmed | HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. | 2.83e-04 | 15 | 58 | 2 | 22530760 | |
| Pubmed | Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification. | 2.83e-04 | 15 | 58 | 2 | 23487311 | |
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 22771245 | ||
| Pubmed | Human Asf1 regulates the flow of S phase histones during replicational stress. | 3.23e-04 | 16 | 58 | 2 | 15664198 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.62e-04 | 1061 | 58 | 8 | 33845483 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 14519686 | ||
| Pubmed | Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation. | 3.66e-04 | 17 | 58 | 2 | 19571810 | |
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 14645126 | ||
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 23118302 | ||
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 16950123 | ||
| Pubmed | 5.06e-04 | 1116 | 58 | 8 | 31753913 | ||
| Pubmed | Extraembryonic proteases regulate Nodal signalling during gastrulation. | 5.62e-04 | 21 | 58 | 2 | 12447384 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 17119020 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 21896659 | ||
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 23552073 | ||
| Pubmed | 7.52e-04 | 106 | 58 | 3 | 18654987 | ||
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 34004147 | ||
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 8.00e-04 | 25 | 58 | 2 | 23563309 | |
| Pubmed | Regulation of planar cell polarity by Smurf ubiquitin ligases. | 8.00e-04 | 25 | 58 | 2 | 19379695 | |
| Pubmed | 1.15e-03 | 30 | 58 | 2 | 31043422 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.18e-03 | 475 | 58 | 5 | 31040226 | |
| Pubmed | 1.23e-03 | 31 | 58 | 2 | 24292274 | ||
| Pubmed | 1.57e-03 | 35 | 58 | 2 | 19498464 | ||
| GeneFamily | Carboxypeptidases | 1.03e-03 | 21 | 41 | 2 | 1321 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ATR ATRX BRDT PTPRK RBM45 PCSK6 DZIP3 NASP RNF213 HERC1 ALG13 | 4.08e-06 | 778 | 55 | 11 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATR ATRX BRDT PTPRK RBM45 PCSK6 DZIP3 NASP RNF213 HERC1 ALG13 | 5.02e-06 | 795 | 55 | 11 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 5.93e-06 | 382 | 55 | 8 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 6.52e-06 | 387 | 55 | 8 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.64e-05 | 776 | 55 | 10 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | 3.80e-05 | 810 | 55 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 5.30e-05 | 379 | 55 | 7 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 6.05e-05 | 387 | 55 | 7 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 1.47e-04 | 770 | 55 | 9 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.90e-04 | 110 | 55 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 2.04e-04 | 804 | 55 | 9 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.07e-04 | 806 | 55 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-07 | 192 | 58 | 6 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.32e-07 | 199 | 58 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 154 | 58 | 5 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 154 | 58 | 5 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 154 | 58 | 5 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-06 | 156 | 58 | 5 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-06 | 156 | 58 | 5 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 3.45e-06 | 177 | 58 | 5 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 4.16e-06 | 184 | 58 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 4.39e-06 | 186 | 58 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 186 | 58 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.51e-06 | 187 | 58 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.62e-06 | 188 | 58 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.62e-06 | 188 | 58 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-06 | 191 | 58 | 5 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.25e-06 | 193 | 58 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-06 | 197 | 58 | 5 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.25e-06 | 200 | 58 | 5 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.89e-05 | 121 | 58 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.21e-05 | 126 | 58 | 4 | 8b689886ce35ff798aea603cde9ccb0dc9d1fd03 | |
| ToppCell | (03)_Secretory-(1)_24hpi|(03)_Secretory / shred by cell type and Timepoint | 2.90e-05 | 135 | 58 | 4 | 6e473296dfe1ff7a63d701e56920c0a1b043ddc6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.84e-05 | 145 | 58 | 4 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.63e-05 | 160 | 58 | 4 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-05 | 160 | 58 | 4 | e44b3c74c76b4632ada7f5bd6d09434b02d79743 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-05 | 165 | 58 | 4 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.49e-05 | 166 | 58 | 4 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 167 | 58 | 4 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-05 | 168 | 58 | 4 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.96e-05 | 169 | 58 | 4 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.12e-05 | 170 | 58 | 4 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-05 | 172 | 58 | 4 | 3f894c74916d49a995b2d4651ca1c6733c14ce9c | |
| ToppCell | Healthy-Plasmablast|World / disease group, cell group and cell class | 7.79e-05 | 174 | 58 | 4 | 6becb456d8f44a1224c6d42be78d4c8cdb51f199 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 7.79e-05 | 174 | 58 | 4 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 7.96e-05 | 175 | 58 | 4 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.96e-05 | 175 | 58 | 4 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.96e-05 | 175 | 58 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-05 | 178 | 58 | 4 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-05 | 178 | 58 | 4 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 8.69e-05 | 179 | 58 | 4 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.69e-05 | 179 | 58 | 4 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-05 | 180 | 58 | 4 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-05 | 180 | 58 | 4 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-05 | 180 | 58 | 4 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.88e-05 | 180 | 58 | 4 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.07e-05 | 181 | 58 | 4 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 9.07e-05 | 181 | 58 | 4 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.07e-05 | 181 | 58 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 9.07e-05 | 181 | 58 | 4 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.27e-05 | 182 | 58 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.27e-05 | 182 | 58 | 4 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.47e-05 | 183 | 58 | 4 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 183 | 58 | 4 | dd15e1463a0d57d14800de0df0645c81c56926ae | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.47e-05 | 183 | 58 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.47e-05 | 183 | 58 | 4 | 8ace19c38b89556d2504258a63aa5a2b14f5cd36 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.67e-05 | 184 | 58 | 4 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.87e-05 | 185 | 58 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.87e-05 | 185 | 58 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 186 | 58 | 4 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 186 | 58 | 4 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 187 | 58 | 4 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 1.05e-04 | 188 | 58 | 4 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 189 | 58 | 4 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.07e-04 | 189 | 58 | 4 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 1.09e-04 | 190 | 58 | 4 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.09e-04 | 190 | 58 | 4 | 3d45d5011305f13634013d9eeb98f235517dd54e | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.09e-04 | 190 | 58 | 4 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 190 | 58 | 4 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 191 | 58 | 4 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 58 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 191 | 58 | 4 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 1.14e-04 | 192 | 58 | 4 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class | 1.16e-04 | 193 | 58 | 4 | bffd97a73365e1dd23ff3b0320b4860f04ec091a | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.16e-04 | 193 | 58 | 4 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.16e-04 | 193 | 58 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 193 | 58 | 4 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 193 | 58 | 4 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 193 | 58 | 4 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 193 | 58 | 4 | 0373984547cefc0cbd77f8e795d508f6fcebc6c8 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.16e-04 | 193 | 58 | 4 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 194 | 58 | 4 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 194 | 58 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 194 | 58 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.19e-04 | 194 | 58 | 4 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 194 | 58 | 4 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 194 | 58 | 4 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Unfolded_protein_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-04 | 195 | 58 | 4 | 9873de83b67e9645112897d3391c2d9afaa9970e | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 1.23e-04 | 196 | 58 | 4 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 197 | 58 | 4 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| Disease | response to stress | 3.67e-06 | 2 | 57 | 2 | GO_0006950 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 1.02e-04 | 8 | 57 | 2 | EFO_0800533 | |
| Disease | major depressive episode | 1.04e-04 | 47 | 57 | 3 | EFO_0007634 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 1.49e-04 | 53 | 57 | 3 | EFO_0001422, EFO_0003095 | |
| Disease | Liver carcinoma | 4.32e-04 | 507 | 57 | 6 | C2239176 | |
| Disease | migraine disorder, systolic blood pressure | 5.50e-04 | 18 | 57 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 5.50e-04 | 18 | 57 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | myocardial infarction | 5.76e-04 | 350 | 57 | 5 | EFO_0000612 | |
| Disease | cerebral infarction (is_marker_for) | 6.14e-04 | 19 | 57 | 2 | DOID:3526 (is_marker_for) | |
| Disease | albuminuria | 8.09e-04 | 94 | 57 | 3 | EFO_0004285 | |
| Disease | migraine disorder, diastolic blood pressure | 1.07e-03 | 25 | 57 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | Nephrotic Syndrome | 1.25e-03 | 27 | 57 | 2 | C0027726 | |
| Disease | longevity, healthspan, parental longevity | 1.44e-03 | 29 | 57 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.54e-03 | 30 | 57 | 2 | EFO_0000341, EFO_0004351 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.56e-03 | 118 | 57 | 3 | EFO_0001645, EFO_0004629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLHNQGIGVSLAQFY | 141 | O60566 | |
| VLQYYFNLGLQCYYH | 981 | Q9NP73 | |
| YNPVDVNALGLHNYY | 296 | Q58F21 | |
| YTAVHYAAAYGNRQN | 551 | Q8NB46 | |
| QHYVISLNGFLQGYN | 176 | Q9UN42 | |
| GYLNTGYQRQLNYKH | 1006 | P01023 | |
| ILYHGYSLLYVQGNE | 1466 | P02462 | |
| GAAQNYYSPINLYHS | 71 | O94779 | |
| DPYSNYGHGVVQYFN | 281 | Q8IUH3 | |
| TNQYSAALHYYLQAG | 846 | Q75QN2 | |
| GLQNYTLSANGYFHL | 166 | Q9Y5F3 | |
| QQVFYLGHYYADLGQ | 256 | O75106 | |
| RQLYYFAQQNSGHFL | 411 | Q15306 | |
| YRAYSGNLYHNGEQT | 2111 | Q15751 | |
| NLGQIGNLEDYYHFY | 96 | P29122 | |
| AGVNPSANYHALYRY | 211 | O95279 | |
| QNLVAYQYGHHVYYT | 296 | Q9NQV6 | |
| SFFHYSQGQVYLGNY | 86 | O95297 | |
| AGNYTAHQINIGYYL | 121 | Q86Y13 | |
| THYQLGLAYGYNSQY | 586 | P49321 | |
| YHMYGQHIGVLNVYL | 841 | Q7Z553 | |
| LIIHHANYYYNNTDG | 321 | O00254 | |
| NSLVYFAYYHGLLGN | 216 | P10619 | |
| YGQYAHATSDYGLQN | 731 | Q96MT3 | |
| YHGQEFIRVGYYVNN | 101 | Q9NVP2 | |
| LYQYYLDHLTGVGNN | 1846 | P46100 | |
| HFGRSLQYGNQFIYQ | 2071 | Q13535 | |
| NYLYVTYNGQEHDVN | 956 | P31327 | |
| SYSRNHTYNTYIGQG | 306 | Q96AY3 | |
| GHITQFYGIIGQYTN | 196 | Q96IY4 | |
| VHGYAFLNTNNGYIL | 551 | Q7Z3S7 | |
| QNVYYHLTGELYVGQ | 531 | Q9NY28 | |
| NNFNYGAYHSLEAIY | 116 | Q9UI42 | |
| TLYNVLLAYGHHNQG | 136 | Q5TC63 | |
| YHGNGQSYQGTYFIT | 941 | P08519 | |
| SRLGYNNYFYGQLHV | 76 | P56915 | |
| HTDFGNINGCYLNYY | 521 | Q8N697 | |
| AGTNHVVYNGSLYFN | 291 | Q96PB7 | |
| GTGHVVYQGAFYYNR | 466 | Q68BL7 | |
| INANYIDGYQRPSHY | 941 | Q15262 | |
| YQAIGAYYIQHTCFQ | 261 | Q13835 | |
| IYYFGGQNAHNQIAI | 496 | Q9BYC5 | |
| LYYYGHQNQSQDLEL | 956 | Q68CR1 | |
| VGYNPYSHLAYNNYR | 26 | Q969G3 | |
| YSHLAYNNYRLGGNP | 31 | Q969G3 | |
| GGQQLSGVNAIYYYA | 286 | P22732 | |
| SDYGYHLRGNEVLYN | 1016 | P30876 | |
| NDLRHGHGVYYYINN | 96 | Q8WYR4 | |
| VLFHNTIYYNLLYGN | 556 | O75027 | |
| SLYDALNQYYVHLGG | 3111 | Q63HN8 | |
| LNQYYVHLGGQKYVD | 3116 | Q63HN8 | |
| AYNAYRAVYAVAHGL | 386 | Q7RTX1 | |
| QASGGHYYSYIIQRN | 1876 | O00507 | |
| NYIFTHIGNGSNYIK | 156 | Q9UJU3 | |
| HPALAQSLYYGQYAY | 1071 | Q9ULD9 | |
| HNGYYFSYVKAQEGQ | 331 | P0C7I0 | |
| NLNLGRTYASGYAHY | 301 | Q9Y3S2 | |
| YHHYFQQGPYAAIQG | 421 | Q9UMR3 | |
| SYGFYLIHTQGQNGL | 466 | Q9UKW4 | |
| DYFHHQDGYRYNVNQ | 436 | Q92802 |